Page last updated: 2024-10-29

isoflurane and Ornithine Carbamoyltransferase Deficiency Disease

isoflurane has been researched along with Ornithine Carbamoyltransferase Deficiency Disease in 2 studies

Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.

Ornithine Carbamoyltransferase Deficiency Disease: An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, J2
Schroth, M2
Irouschek, A2
Birkholz, T2
Kurzai, M1
Kröber, S1
Meisner, M1
Albrecht, S2
Kroeber, S1

Other Studies

2 other studies available for isoflurane and Ornithine Carbamoyltransferase Deficiency Disease

ArticleYear
[Patients with ornithine transcarbamylase deficiency. Anaesthesiological and intensive care management].
    Der Anaesthesist, 2005, Volume: 54, Issue:12

    Topics: Adjuvants, Anesthesia; Adolescent; Anesthesia; Anesthesia, General; Anesthetics, Dissociative; Anest

2005
Anesthetic management of patients with ornithine transcarbamylase deficiency.
    Paediatric anaesthesia, 2006, Volume: 16, Issue:3

    Topics: Anesthesia, General; Anesthetics, Combined; Catheterization, Central Venous; Catheters, Indwelling;

2006